Osagie Imasogie is the Senior Managing Partner of Phoenix IP Ventures and the Chairman of Quoin’s Advisory Board. Osagie has over 30 years of experience in the fields of law, finance and business management, healthcare and the pharmaceutical industry.  Prior to co-founding Phoenix IP Ventures, an IP based Merchant Bank, Osagie conceptualized and established GlaxoSmithKline Ventures.  Osagie has been a senior executive at SmithKline Beecham, DuPont Merck and the Founding SVP for Business Development and General Counsel at Endo Pharmaceuticals Inc. Osagie is Chairman of the Board of Directors of Iroko Pharmaceuticals and iCeutica Pharmaceuticals, Inc and serves on the Board of StoneRidge Investment Partners, a money management Firm. Osagie has also been a Price Waterhouse Corporate Finance Partner as well as a practicing attorney with a leading US Law Firm in the fields of corporate, corporate finance, taxation and intellectual property law.

Osagie holds post-graduate degrees from the London School of Economics and the University of Pennsylvania Law School, is a member of the New York State Bar and has been the I Grant Irey Adjunct Professor at the University of Pennsylvania Law School where he teaches a seminar on “Intellectual Property and National Economic Value Creation.”